Good afternoon, everyone, and welcome to IonQ's First Quarter 2026 Earnings Call. My name is Hanley Donofrio, and I am the Investor Relations Director here at IonQ. I'm pleased to be joined on today's ...

Pancreatic cancer remains one of the most difficult cancers to treat, with many patients facing a high risk of recurrence ...

Looking ahead to 2030, our model projects MRNA could trade at an average price of $46.81, with a potential range between $35.10 and $58.51. This represents a potential 13.9% decline from today's price ...

Once powerful AI models are released, it’s nearly impossible to keep them from being misused. Minimizing the risk means ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Lars Peterson joined Investopedia in 2023 as a senior editor of financial product ...